RESUMO
A combination of chemotherapy with a "second-look" operation has its place in a long-tern treatment of ovarian cancer of stage III, though it will hardly improve the long-term results--the 5-year survival in this stage. Ocassionally, this combination may prove useful and even decisive for prolonging life and even bringing about recovery. This would apply to less advanced, better cases of stage III and to carcinomas with a lesser biological malignancy. "Second-look" operations may be indicated not only in an improvement of the local finding as has been reported up to now by several authors, but also if this local finding has not improved but the patients overall condition is satisfactory or has not deteriorated since the first laparotomy, especially if the latter had been performed at another hospital. The time for the second-look operation must be determined individually according to the clinical course.
Assuntos
Neoplasias Ovarianas/terapia , Adenocarcinoma Papilar/terapia , Adenoma/terapia , Antineoplásicos/uso terapêutico , Cistadenoma/terapia , Feminino , Humanos , Neoplasias Ovarianas/tratamento farmacológico , Neoplasias Ovarianas/cirurgia , Fatores de TempoRESUMO
Relationship between hemoglobin level and survival and/or recurrence rate was studied in radiation treated group of postmenopausal women with uterine cervix carcinoma. The data suggest that anemia alters unfavorably the effectiveness of radiotherapy. A possible explanation of the lowered control rate is that due to deficiency of tissue oxygenation by reduced oxygen carriage proportion of hypoxic cells increases and impairs the radiosensitivity.